Allosteric mechanisms in normal and pathological nicotinic acetylcholine receptors

Current Opinion in Neurobiology

Volumn 11, Issue 3, 2001, Pages 369-377

  Changeux, Jean Pierre ^a   Edelstein, Stuart J ^b  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ION; MUTANT PROTEIN; NICOTINIC RECEPTOR; RECEPTOR SUBUNIT;

ALLOSTERISM; BINDING SITE; CELLULAR DISTRIBUTION; CONSCIOUSNESS; DELETION MUTANT; HUMAN; MULTIGENE FAMILY; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION;

EID: 0035368723     PISSN: 09594388     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-4388(00)00221-X     Document Type: Review

References (111)

1. Allosteric receptors after 30 years
2. Neurobiology of the Caenorhabditis elegans genome
3. The ligand gated ion channel database
4. Intercellular communication in the brain: Wiring versus volume transmission
5. Tonic nicotinic modulation of serotoninergic transmission in the spinal cord
6. A reporter mutation approach shows incorporation of the 'orphan' subunit β3 into a functional nicotinic receptor
7. Single channel properties of human α3 AChRs: Impact of β2, β4 and α5 subunits
8. Functional α6-containing nicotinic receptors are present in chick retina
9. Human α6 AChR subtypes: Subunit composition, assembly, and pharmacological responses
10. Nicotinic acetylcholine receptors assembled from the α7 and β3 subunits
11. Diversity and distribution of nicotinic acetylcholine receptors in the locus ceruleus neurons
12. Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei
13. Development of the vertebrate neuromuscular junction
14. Different functions of fetal and adult AChR subtypes for the formation and maintenance of neuromuscular synapses revealed in ε-subunit-deficient mice
15. The long internal loop of the α3 subunit targets nAChRs to subdomains within individual synapses on neurons in vivo
16. Neuronal acetylcholine receptors with α7 subunits are concentrated on somatic spines for synaptic signaling in embryonic chick ciliary ganglia
17. Receptors with opposing functions are in postsynaptic microdomains under one presynaptic terminal
18. Postsynaptic nicotinic receptors on dopaminergic neurons in the substantia nigra pars compacta of the rat
19. Ultrastructural localization of the α4-subunit of the neuronal acetylcholine nicotinic receptor in the rat substantia nigra
20. Clustering of inhibitory neurotransmitter receptors at developing postsynaptic sites: The membrane activation model
21. Formation of glycine receptor clusters and their accumulation at synapses
22. PSD-95 involvement in maturation of excitatory synapses
23. Presynaptic ionotropic receptors and the control of transmitter release
24. 2+ ions in nicotinic facilitation of GABA release in mouse thalamus
25. Neural networks that learn temporal sequences by selection
26. Inhibition and disinhibition of pyramidal neurons by activation of nicotinic receptors on hippocampal interneurons
27. Nicotinic receptors on hippocampal cultures can increase synaptic glutamate currents while decreasing the NMDA-receptor component
28. Structure of a glutamate-receptor ligand-binding core in complex with kainate
29. Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: Crystal structures of the GluR2 ligand binding core
30. How well can molecular modelling predict the crystal structure: The case of the ligand-binding domain of glutamate receptors
31. Improved secondary structure predictions for a nicotinic receptor subunit: Incorporation of solvent accessibility and experimental data into a two-dimensional representation
32. Nicotinic receptors at the amino acid level
33. From ab initio quantum mechanics to molecular neurobiology: A cation-π binding site in the nicotinic receptor
34. Mapping the agonist binding site of the nicotinic acetylcholine receptor. Orientation requirements for activation by covalent agonist
35. Structural differences in the two agonist binding sites of the Torpedo nicotinic acetylcholine receptor revealed by time-resolved fluorescence spectroscopy
36. Critical elements determining diversity in agonist binding and desensitization of neuronal nicotinic acetylcholine receptors
37. Desensitization of neuronal nicotinic acetylcholine receptors conferred by N-terminal segments of the β2 subunit
38. Mutational analysis of the charge selectivity filter of the α7 nicotinic acetylcholine receptor
39. The location of the gate in the acetylcholine receptor channel
40. M2 pore mutations convert the glycine receptor channel from being anion- to cation-selective
41. + conduction and selectivity
42. Backbone mutations in transmembrane domains of a ligand-gated ion channel: Implications for the mechanism of gating
43. Nicotinic acetylcholine receptor at 4.6Å resolution: Transverse tunnels in the channel wall
44. Structural elements near the C-terminus are responsible for changes in nicotinic receptor gating kinetics following patch excision
45. Mutation causing congenital myasthenia reveals acetylcholine receptor β/Δ subunit interaction essential for assembly
46. The emerging three-dimensional structure of a receptor. The nicotinic acetylcholine receptor
47. Inhibition of nicotinic acetylcholine receptor by philanthotoxin-343: Kinetic investigations in the microsecond time region using a laser-pulse photolysis technique
48. Fundamental gating mechanism of nicotinic receptor channel revealed by mutation causing a congenital myasthenic syndrome
49. Distance between the agonist and noncompetitive inhibitor sites on the nicotinic acetylcholine receptor
50. Myasthenic nicotinic receptor mutant interpreted in terms of the allosteric model
51. Congenital myasthenic syndrome caused by prolonged acetylcholine receptor channel openings due to a mutation in the M2 domain of the ε subunit
52. Paradoxical allosteric effects of competitive inhibitors on neuronal α7 nicotinic receptor mutants
53. Kinetic, mechanistic, and structural aspects of unliganded gating of acetylcholine receptor channels: A single-channel study of second transmembrane segment 12′ mutants
54. Mutations in the channel domain alter desensitization of a neuronal nicotinic receptor
55. Mutation of an arginine residue transforms β-alanine and taurine from agonists into competitive antagonists
56. The Lurcher mutation of an α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor subunit enhances potency of glutamate and converts an antagonist to an agonist
57. Contributions of Torpedo nicotinic acetylcholine receptor γTrp-55 and δTrp-57 to agonist and competitive antagonist function
58. Single bindings versus single channel recordings: A new approach to ionotropic receptors
59. Acetylcholine and epibatidine binding to muscle acetylcholine receptors distinguish between concerted and uncoupled models
60. Binding properties of agonists and antagonists to distinct allosteric states of the nicotinic acetylcholine receptor are incompatible with a concerted model
61. Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor
62. Cell signaling by receptor tyrosine kinases
63. On the cooperativity of biological membranes
64. Different channel properties of Torpedo acetylcholine receptor monomers and dimers reconstituted in planar membranes
65. Acetylcholine receptors are not functionally independent
66. Incorporation of the acetylcholine receptor dimer from Torpedo californica in a peptide supported lipid membrane investigated by surface plasmon and fluorescence spectroscopy
67. Heightened sensitivity of a lattice of membrane receptors
68. T cell antigen receptor signal transduction
69. Cryoelectron microscopy and image analysis of the cardiac ryanodine receptor
70. Fluorescence-imaged microdeformation of the outer hair cell lateral wall
71. State-dependent cross-inhibition between transmitter-gated cation channels
72. Congenital myasthenic syndromes: Recent advances
73. Mode switching kinetics produced by a naturally occurring mutation in the cytoplasmic loop of the human acetylcholine receptor ε subunit
74. Acetylcholine receptor M3 domain: Stereochemical and volume contributions to channel gating
75. Neuronal nicotinic receptors in human epilepsy
76. The nicotinic receptor β2 subunit is mutant in nocturnal frontal lobe epilepsy
77. Prenatal nicotine increases pulmonary α7 nicotinic receptor expression and alters fetal lung development in monkeys
78. α7 is upregulated in the TG2576 mouse model of Alzheimer's disease
79. β-Amyloid(1-42) binds to β7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology
80. Inhibitory neurophysiological deficit as a phenotype for genetic investigation of schizophrenia
81. Haplotypes of four novel single nucleotide polymorphisms in the nicotinic acetylcholine receptor β2-subunit (CHRNB2) gene show no association with smoking initiation or nicotine dependence
82. Nicotinic receptor function: New perspectives from knockout mice
83. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits
84. Phenotypic characterization of an α4 neuronal nicotinic acetylcholine receptor subunit knock-out mouse
85. Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine
86. Increased neurodegeneration during ageing in mice lacking high-affinity nicotine receptors
87. Megacystis, mydriasis, and ion channel defect in mice lacking the α3 neuronal nicotinic acetylcholine receptor
88. Multiorgan autonomic dysfunction in mice lacking the β2 and the β4 subunits of neuronal nicotinic acetylcholine receptors
89. Emotional memory impairment in transgenic mice with a mutant form of the nicotinic receptor α7 subunits
90. Knockin mice with hypersensitive neuronal nicotinic receptors
91. Neuronal nicotinic receptors in the human brain
92. Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine α4β2 receptor
93. Chronic nicotine treatment up-regulates α3 and α7 acetylcholine receptor subtypes expressed by the human neuroblastoma cell line SH- SY5Y
94. Chronic nicotine treatment up-regulates human α3β2 but not α3β4 acetylcholine receptors stably transfected in human embryonic kidney cells
95. Upregulation of surface α4β2 nicotinic receptors is initiated by receptor desensitization after chronic exposure to nicotine
96. Agonist-induced up-regulation of α4β2 nicotinic acetylcholine receptors in M10 cells: Pharmacological and spatial definition
97. Dependence of nicotinic acetylcholine receptor recovery from desensitization on the duration of agonist exposure
98. Ion channel assembly: Creating structures that function
99. Determinants responsible for assembly of the nicotinic acetylcholine receptor
100. Nicotinic receptor: A prototype of allosteric ligand-gated ion channels and its possible implications in epilepsy
101. Nicotinic acetylcholine receptor knockout mice as animal models for studying receptor function
102. A neuronal model of a global workspace in effortful cognitive tasks
103. Sur les propritétés allostériques de la L-thréonine et de la L-leucine sur la L-thréonine désaminase. VI. Discussion générale
104. Acetylcholine receptor channel structure in the resting, open, and desensitized states probed with the substituted-cysteine-accessibility method
105. Point mutant mice with hypersensitive α 4 nicotinic receptors show dopaminergic deficits and increased anxiety
106. β-Amyloid peptide blocks the response of α7-containing nicotinic receptors on hippocampal neurons
107. β-Amyloid(1-42) peptide directly modulates nicotinic receptors in the rat hippocampal slice
108. Chronic exposure to nicotine upregulates the human (α)4(β)2 nicotinic acetylcholine receptor function
109. Acetylcholine in mind: A neurotransmitter correlate of consciousness?
110. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors
111. A glia-derived acetylcholine-binding protein that modulates synaptic transmission